Allergen Research Corporation Obtains $17,000,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cf05d52e-67b5-4972-86b9-c0d6cadd3fbb
Date
11/22/2013
Company Name
Allergen Research Corporation
Mailing Address
2000 Alameda De Las Pulgas San Mateo, CA 94403
Company Description
Allergen Research Corporation (ARC) develops treatments to protect children with food allergies from the threatening consequences of accidental exposure.
Website
http://www.allergenresearch.com
Transaction Type
Venture Equity
Transaction Amount
$17,000,000
Transaction Round
Undisclosed
Proceeds Purposes
The company intends to use the funds to support its upcoming Phase 2b clinical trial to evaluate peanut allergy oral immunotherapy (OIT) with characterized peanut allergen (CPNA), as well as related development projects.
M&A Terms
Venture Investor
Longitude Capital Management
Venture Investor
Undisclosed